A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?

NCT02106234 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
660
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Maastricht University Medical Center